Analysis Demonstrates Effectiveness of LY-CoV555 Antibody in Preventing Symptomatic COVID-19
25 janv. 2021 17h59 HE
|
COVID-19 Prevention Network
DURHAM, N.C., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Researchers from the COVID-19 Prevention Network (CoVPN) announced that the monoclonal antibody (mAb), LY-CoV555 (bamlanivimab), evaluated in...